| # | Title | Journal | Year | Citations |
|---|
| 1 | Small molecule inhibitors reveal Niemann–Pick C1 is essential for Ebola virus infection | Nature | 2011 | 601 |
| 2 | An Update on the Potential of North American Mosquitoes (Diptera: Culicidae) to Transmit West Nile Virus | Journal of Medical Entomology | 2005 | 581 |
| 3 | Vector Competence of North American Mosquitoes (Diptera: Culicidae) for West Nile Virus | Journal of Medical Entomology | 2001 | 537 |
| 4 | Postexposure protection of non-human primates against a lethal Ebola virus challenge with RNA interference: a proof-of-concept study | Lancet, The | 2010 | 414 |
| 5 | Exotic emerging viral diseases: progress and challenges | Nature Medicine | 2004 | 411 |
| 6 | Treatment of Ebola virus infection with a recombinant inhibitor of factor VIIa/tissue factor: a study in rhesus monkeys | Lancet, The | 2003 | 362 |
| 7 | Smallpox vaccine–induced antibodies are necessary and sufficient for protection against monkeypox virus | Nature Medicine | 2005 | 346 |
| 8 | Mechanisms Underlying Coagulation Abnormalities in Ebola Hemorrhagic Fever: Overexpression of Tissue Factor in Primate Monocytes/Macrophages Is a Key Event | Journal of Infectious Diseases | 2003 | 336 |
| 9 | Ebola virus entry requires the host-programmed recognition of an intracellular receptor | EMBO Journal | 2012 | 284 |
| 10 | Pathogenesis of Experimental Ebola Virus Infection in Guinea Pigs | Journal of Infectious Diseases | 1999 | 278 |
| 11 | Potent cross-reactive neutralization of SARS coronavirus isolates by human monoclonal antibodies | Proceedings of the National Academy of Sciences of the United States of America | 2007 | 276 |
| 12 | Smallpox DNA Vaccine Protects Nonhuman Primates against Lethal Monkeypox | Journal of Virology | 2004 | 267 |
| 13 | Marburg Virus Vaccines Based upon Alphavirus Replicons Protect Guinea Pigs and Nonhuman Primates | Virology | 1998 | 254 |
| 14 | Non-neutralizing monoclonal antibodies can prevent lethal alphavirus encephalitis | Nature | 1982 | 248 |
| 15 | Effective Post-Exposure Treatment of Ebola Infection | PLoS Pathogens | 2007 | 246 |
| 16 | Ebola virus: The role of macrophages and dendritic cells in the pathogenesis of Ebola hemorrhagic fever | International Journal of Biochemistry and Cell Biology | 2005 | 244 |
| 17 | A Lethal Disease Model for Hantavirus Pulmonary Syndrome | Virology | 2001 | 229 |
| 18 | Potential for New York mosquitoes to transmit West Nile virus. | American Journal of Tropical Medicine and Hygiene | 2000 | 228 |
| 19 | Development of a New Vaccine for the Prevention of Lassa Fever | PLoS Medicine | 2005 | 223 |
| 20 | A broad-spectrum antiviral targeting entry of enveloped viruses | Proceedings of the National Academy of Sciences of the United States of America | 2010 | 214 |
| 21 | Four-gene-combination DNA vaccine protects mice against a lethal vaccinia virus challenge and elicits appropriate antibody responses in nonhuman primates | Virology | 2003 | 205 |
| 22 | Folate Receptor-α Is a Cofactor for Cellular Entry by Marburg and Ebola Viruses | Cell | 2001 | 200 |
| 23 | Interferon-β 1a and SARS Coronavirus Replication | Emerging Infectious Diseases | 2004 | 173 |
| 24 | DNA Vaccination with Vaccinia Virus L1R and A33R Genes Protects Mice against a Lethal Poxvirus Challenge | Virology | 2000 | 169 |
| 25 | Characterization of Hantaan Virus Envelope Glycoprotein Antigenic Determinants Defined by Monoclonal Antibodies | Journal of General Virology | 1989 | 166 |
| 26 | DNA Vaccines Expressing either the GP or NP Genes of Ebola Virus Protect Mice from Lethal Challenge | Virology | 1998 | 166 |
| 27 | Generation of eGFP expressing recombinant Zaire ebolavirus for analysis of early pathogenesis events and high-throughput antiviral drug screening | Virology | 2005 | 166 |
| 28 | Postexposure protection against Marburg haemorrhagic fever with recombinant vesicular stomatitis virus vectors in non-human primates: an efficacy assessment | Lancet, The | 2006 | 166 |
| 29 | A Serological Point-of-Care Test for the Detection of IgG Antibodies against Ebola Virus in Human Survivors | ACS Nano | 2018 | 163 |
| 30 | Cyanovirin-N binds to the viral surface glycoprotein, GP1,2 and inhibits infectivity of Ebola virus | Antiviral Research | 2003 | 159 |
| 31 | Smallpox DNA vaccine delivered by novel skin electroporation device protects mice against intranasal poxvirus challenge | Vaccine | 2007 | 153 |
| 32 | Longitudinal Analysis of the Human B Cell Response to Ebola Virus Infection | Cell | 2019 | 153 |
| 33 | Individual and Bivalent Vaccines Based on Alphavirus Replicons Protect Guinea Pigs against Infection with Lassa and Ebola Viruses | Journal of Virology | 2001 | 148 |
| 34 | Development of Clinical-Stage Human Monoclonal Antibodies That Treat Advanced Ebola Virus Disease in Nonhuman Primates | Journal of Infectious Diseases | 2018 | 146 |
| 35 | Recombinant Human Activated Protein C for the Postexposure Treatment of Ebola Hemorrhagic Fever | Journal of Infectious Diseases | 2007 | 141 |
| 36 | Active and Passive Vaccination against Hantavirus Pulmonary Syndrome with Andes Virus M Genome Segment-Based DNA Vaccine | Journal of Virology | 2003 | 134 |
| 37 | DNA Vaccination with the Hantaan Virus M Gene Protects Hamsters against Three of Four HFRS Hantaviruses and Elicits a High-Titer Neutralizing Antibody Response in Rhesus Monkeys | Journal of Virology | 2001 | 127 |
| 38 | Monkeypox virus detection in rodents using real-time 3′-minor groove binder TaqMan® assays on the Roche LightCycler | Laboratory Investigation | 2004 | 124 |
| 39 | DNA Vaccination with Hantavirus M Segment Elicits Neutralizing Antibodies and Protects against Seoul Virus Infection | Virology | 1999 | 122 |
| 40 | ICTV Virus Taxonomy Profile: Togaviridae | Journal of General Virology | 2018 | 122 |
| 41 | Comparison of individual and combination DNA vaccines for B. anthracis, Ebola virus, Marburg virus and Venezuelan equine encephalitis virus | Vaccine | 2003 | 119 |
| 42 | Immunogenicity of combination DNA vaccines for Rift Valley fever virus, tick-borne encephalitis virus, Hantaan virus, and Crimean Congo hemorrhagic fever virus | Vaccine | 2006 | 117 |
| 43 | A putative receptor for Venezuelan equine encephalitis virus from mosquito cells | Journal of Virology | 1996 | 116 |
| 44 | Naked DNA vaccines expressing the prM and E genes of Russian spring summer encephalitis virus and Central European encephalitis virus protect mice from homologous and heterologous challenge | Journal of Virology | 1997 | 116 |
| 45 | Laboratory Transmission of La Crosse Virus byOchlerotatus j. japonicus(Diptera: Culicidae) | Journal of Medical Entomology | 2002 | 115 |
| 46 | Coding properties of the S and the M genome segments of sapporo rat virus: Comparison to other causative agents of hemorrhagic fever with renal syndrome | Virology | 1990 | 111 |
| 47 | Ebola virus: new insights into disease aetiopathology and possible therapeutic interventions | Expert Reviews in Molecular Medicine | 2004 | 109 |
| 48 | Experimental Vertical Transmission of West Nile Virus byCulex pipiens(Diptera: Culicidae) : Table 1 | Journal of Medical Entomology | 2002 | 108 |
| 49 | Eastern and Venezuelan Equine Encephalitis Viruses Differ in Their Ability To Infect Dendritic Cells and Macrophages: Impact of Altered Cell Tropism on Pathogenesis | Journal of Virology | 2008 | 108 |
| 50 | 3-Deazaneplanocin A induces massively increased interferon-α production in Ebola virus-infected mice | Antiviral Research | 2002 | 106 |
